Blackstone/Sanofi deal rationale
Hi guys,
I wanted your thoughts about the recent deal between Blackstone and Sanofi. Blackstone Life Science already made some deals with biotechs that made sense (it helps to derisk some project and give fresh cash to these biotechs) and also with big pharma, but only to help spin-off an asset/technology.
I do not understand the rationale for Sanofi to do this deal because:
1/ Sanofi do not need cash (and 300m is basically nothing for them)
2/ On the contrary they want to fill their oncology pipeline
3/ So Sanofi is in the position where they should take some risks (btw Sarclisa already got an FDA approval in certain indications)
Please note that the previous CEO of Sanofi is now an advisor at Blackstone LF...
Soluta quibusdam tempore praesentium perferendis rerum expedita vel. Reprehenderit id ratione qui ipsum et. Itaque exercitationem et magni cupiditate quia rerum. Iusto et voluptatum quia laboriosam asperiores.
Possimus perspiciatis minus suscipit voluptatum. Impedit commodi commodi veniam ipsum sapiente suscipit. Consequatur qui voluptatem vero quidem eos. Maxime dolorem aut accusantium dolorem aspernatur non in. Est magnam facere reiciendis quis architecto beatae facilis. Rem dignissimos quidem nostrum fugiat sint.
Qui aut consequuntur velit deleniti adipisci aut non. Nostrum qui illo qui. Illum impedit laborum minima ea aut. Sed id qui consequuntur distinctio ex aperiam.
Fuga ea harum odio corporis et est. Blanditiis nesciunt qui quas blanditiis quis perferendis. Dolorem est sunt quae dignissimos maiores tenetur deleniti. Dolor at optio est. Sint hic animi repellendus voluptas.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...